Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Heterogeneity of acetylcholine receptor autoantibody-mediated complement activity in patients with myasthenia gravis

medRxiv(2021)10.1101/2021.10.05.21264566Source: DataRank Database

Heterogeneity of acetylcholine receptor autoantibody-mediated complement activity in patients with myasthenia gravis is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (24)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Chryssa Zografou,Douangsone D. Vadysirisack,Bailey Munro-Sheldon,Miriam L. Fichtner ORCID,Bhaskar Roy ORCID

Live enrichment

PubMed:20819859 OpenAlex:https://openalex.org/W3204062692

National Institutes of Health

Grant: 5U54NS115054-03

Rare Disease Network for Myasthenia Gravis

National Institutes of Health

Grant: 4R01EY022936-04

Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica

National Institutes of Health

Grant: 5R01AI114780-04

Mechanisms of autoantibody production in myasthenia gravis

National Institutes of Health

Grant: 1R21AI164590-01

Molecular determinants driving diverse mechanisms of antibody-mediated pathology

National Institutes of Health

Grant: 1R21EY032399-01

In vivo modeling of autoantibody-induced optic neuritis

greenLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/03/06/2021.10.05.21264566.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.10.05.21264566

repositoryhttps://doi.org/10.1101/2021.10.05.21264566

https://www.medrxiv.org/content/medrxiv/early/2021/10/07/2021.10.05.21264566.full.pdf

Fields of Study

Myasthenia Gravis and ThymomaPeripheral Neuropathies and DisordersAntifungal resistance and susceptibility03 medical and health sciences0302 clinical medicine

Keywords

AutoantibodyMyasthenia gravisAcetylcholine receptorComplement systemImmunologyCD59MedicineReceptorChemistryAntibodyMolecular biologyInternal medicineBiologyHEK293 CellsHumansReceptors, CholinergicComplement ActivationResearch ArticleAutoantibodies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being